交易中 03-26 10:46:06 美东时间
+0.130
+1.38%
今日重点评级关注:HC Wainwright & Co.:维持Altimmune"买入"评级,目标价从12美元升至25美元;BTIG:维持Jade Biosciences"买入"评级,目标价从28美元升至39美元
03-17 11:45
B. Riley Securities analyst Timothy D'Agostino maintains Eagle Point Income (NYSE:EIC) with a Buy and lowers the price target from $14 to $11.25.
03-16 23:11
BRIEF-Eagle Point Income Company Inc. Launches Offering Of 6.00% Convertible Perpetual Preferred Stock March 16 (Reuters) - Eagle Point Income Company Inc EIC.N : EAGLE POINT INCOME COMPANY INC. LAUNCHES OFFERING OF 6.00% CONVERTIBLE PERPETUAL PREFERRED STOCK Source text: ID:nBw54FT7Qa Further compa
03-16 20:10
Ladenburg Thalmann analyst Christopher Nolan downgrades Eagle Point Income (NYSE:EIC) from Buy to Neutral.
02-27 22:47
Eagle Point Income Co ( ($EIC) ) has shared an update. On February 26, 2026, Ea...
02-26 20:37
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Eagle Point Income Company Inc. announces $0.11 monthly common dividend for Q2 2026 Eagle Point Income Company Inc. has announced monthly distributions of $0.11 per common share for the second quarter of 2026, with payments scheduled for April, May, and June. The company also declared distributions
02-17 21:02
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
2025-11-21 15:50
Eagle Point Income Company Inc., a publicly-traded, diversified, closed-end management investment company, has released a portfolio/holding disclosure. The company's investment focus is on generating ...
2025-09-12 06:03